Zydus Wellness Share Price Jumps 19% On Q3FY26 Earnings Results; Stock Near Record High

Zydus Wellness share price (NSE: ZYDUSWELL) rose sharply by 19% during Monday’s intraday trade, touching around ₹528 on the BSE and moving close to its all-time high of ₹530.55 reached in September 2025.

By early afternoon, the stock was still up about 15%, clearly outperforming the broader market. 

Zydus Wellness Q3FY26 Financial Performance

The rally followed strong quarterly results for the October–December 2025 quarter:

• Net sales jumped 113.7% YoY to ₹963.3 crore
• EBITDA grew 312.2% YoY to ₹61 crore

Growth was supported by the performance of newly acquired businesses and strong demand across key brands.

Brand Strength Driving Growth

The company owns several well-known consumer health brands including Sugar Free, Glucon-D, Nutralite, Everyuth, Nycil, Complan and RiteBite Max Protein.

Key highlights:

• Sugar Free holds a 96.3% market share in sugar substitutes
• Sugar Free Green has delivered double-digit growth for 19 straight quarters
• The D’lite product range is expanding into new markets

About Zydus Wellness

Zydus Wellness is an Indian consumer goods company that manufactures nutrition and skincare products. Headquartered in Ahmedabad, it operates as a subsidiary of Zydus Lifesciences and owns popular brands such as Glucon-D, Sugar Free, EverYuth, Complan, and Nycil.

Conclusion

Strong financial performance, market-leading brands and sustained demand momentum have boosted investor confidence in Zydus Wellness. The stock’s movement near its record high reflects positive sentiment.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks. Read all the related documents carefully before investing.